FDA Inspection 1226925 — Jeffrey M. Miller, M.D.
The FDA completed an inspection of Jeffrey M. Miller, M.D. on Dec 12, 2023 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 12, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New York, NY (United States)
Additional Details
Sponsor-Investigator (S-I)